SF
Seamus Fernandez Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
34
Avg Return
Past Year
Past Year
39%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
---|---|---|---|---|---|---|---|---|
Buy
Reiterated
| $948 |
18%
upside
| 3 | +2.6% |
0
%
| 16 Oct ‘25 3 days ago |
|
|
Buy
Maintained
| $167 |
64%
upside
| 1 | +56% |
0
%
| 25 Sep ‘25 24 days ago |
|
|
Buy
Maintained
| $84 |
535%
upside
| 1 | +89% |
0
%
| 23 Sep ‘25 26 days ago |
|
|
Buy
Maintained
| $25 |
67%
upside
| 1 | +80% |
0
%
| 15 Sep ‘25 1 month ago |
|
|
Buy
Maintained
| $14 |
110%
upside
| 1 | +13% |
0
%
| 14 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $90 |
229%
upside
| 1 | +68% |
0
%
| 7 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $120 |
9%
upside
| 1 | +49% |
0
%
| 6 Aug ‘25 2 months ago |
|